GMP QC Testing Services
MoA‑reflective bioassay services aligned to your drug’s biology and mechanism
We Care About Your Compliance
GMP QC Testing Services
At Svar Life Science, compliance is built into how we work. Our QC team provides you with quality services from our GMP-certified facilities, in compliance with the latest regulatory requirements. We work closely with our QA and R&D experts to deliver high-quality GMP Bioassay service to support the release, stability, and in-process testing of your drug.
Integrated CMC bioassay services
Potency that reflects the mode of action (MoA) is central to regulatory expectations for biologics. We cover the full QC bioassay lifecycle from feasibility to long-term method monitoring with GMP lot release, stability, and in process testing at the core.
Why choose Svar for GMP QC Testing
-
GMP‑certified bioassay QC with scientific ownership
Direct access to the scientists running your assays, supported by integrated QA and R&D, delivering regulatory confidence, reliable release decisions, and patient safety.
-
MoA‑reflective potency assays built for QC reality
iLite® and custom cell‑based bioassays designed for robustness, transferability, and batch‑to‑batch consistency across release, stability, and in‑process testing.
-
Phase‑appropriate, end‑to‑end assay lifecycle support
Seamless progression from feasibility through development, qualification/validation, and commercial lifecycle monitoring—minimizing late‑phase surprises and accelerating timelines.
-
Embedded trending and lifecycle management for long‑term control
Proactive method trending, performance monitoring, and continuous improvement strategies ensuring sustained assay reliability from early development through commercial release.
Our QC Testing Services Offering
-
QC TESTING SERVICE
We perform early assessments of whether a potency or functional bioassay is fit for purpose, using limited‑plate feasibility to evaluate layout, curve behavior, signal‑to‑noise, variance, data‑transformation needs, and critical reagent performance. This allows to minimize downstream risk and to ensure the assay can be efficiently refined before full development.
-
QC TESTING SERVICE
We perform assay design and refinement to reflect the drug’s mechanism of action, optimizing plate setup, replicate strategy, parallelism/similarity assessment, specificity, and robustness. Early‑phase qualification demonstrates that the method is suitable and reliable for its intended context, establishing broad acceptance criteria aligned with the stage of development.
-
QC TESTING SERVICE
We carry out full GMP validation for late‑phase and commercial readiness according to ICH Q2(R2) (accuracy, precision, specificity, linearity, range, robustness), ICH Q14 (analytical procedure development and lifecycle control), and USP <1032–1034> (bioassay design and validation). This ensures your potency assay meets regulatory expectations for long‑term QC use in lot release and stability testing.
-
QC TESTING SERVICE
We perform routine GMP‑compliant relative potency testing for both drug substance and drug product using ligand‑binding assays (LBA) and cell‑based formats, ensuring the selected assay reflects your drug’s MoA. Release specifications are established together with your team to secure robust, phase‑appropriate batch release.
-
GMP QC TESTING SERVICESWe design and execute potency‑based stability studies under real‑time and accelerated conditions to evaluate product integrity over time. Stability studies are performed during all phases of drug development, including post-licensure studies, which are used to further monitor drug stability. Our GMP QC Services provide potency testing of stability samples to support both GMP and non-GMP stability studies. Additionally, we perform exploratory stability testing.
-
GMP QC TESTING SERVICESWe develop and apply rapid, purpose‑built bioassays to detect unexpected shifts during manufacturing, enabling timely in‑process control decisions. These assays are tailored for sensitivity to process variability and support both GMP and non‑GMP production environments.
-
GMP QC TESTING SERVICESWe execute risk‑based method transfers and ensure long‑term QC performance through continuous lifecycle monitoring — including control sample trending, SST criteria, curve‑fit parameters, and reagent qualification — to maintain method robustness throughout the assay’s lifetime.
Technologies & Formats
-
Cell based bioassays (incl. iLite® reporter gene) for pathway level function (MoA).
-
Ligand Binding Assays (LBA) for affinity/engagement where appropriate.
- Effector function readouts (e.g., ADCC/CDC/ADCP matrices) where clinically relevant.
Modalities & Use Cases
-
Monoclonal and Multi specific antibodies
-
ADCs
-
Fusion/therapeutic proteins
-
Vaccines
-
Advanced therapies (AAV & cell based)
When effector functions contribute to clinical activity, we deploy assay matrices (e.g., NK, ADCC, CDC, binding or reporter surrogates) with phase appropriate justification.
CRO Services News
Advanced LC-MS/MS Technology: A Strategic Partnership with Lablytica
Read post
Svar Life Sciences Offers GMP Potency Testing using Cell-Based Bioassays
Read post
Svar becomes first CRO certified for Olink Proteomics Services in the Nordics!
Read post
Driving Discovery: 600+ Studies Featuring Our Products
Read post
Gearing Up for the Future: Navigating IVDR Compliance
Read post
Svar Life Science & Lablytica Life Science Announce Strategic Partnership
Read postCRO Services Downloads
From Off-the-Shelf to Fit-for-Purpose: IVD-Compliant Biomarker Assay Optimization
Read post
Functional Detection of Neutralizing Antibodies Against Anti-Cancer Biotherapeutics
Read post
The Art of Partnership: Managing Expectations in Pharma-CRO Relationships
Read post
Advancing Precision Medicine: Svar CRO Services + Olink® Technology
Read post
Tailored ADA Assay Solutions: Adapting to Long-Term Immunogenicity Challenges
Read post
Partnering for Progress: Supporting Alentis Therapeutics’ Mission
Read post
Integrating LC-MS and Ligand Binding Assays to Meet Bioanalytical Demands
Read post
Design of Biosimilar Bioanalytical Programs: PK Assay Considerations
Read post
How to Design Potency Assays for Gene Therapy Projects
Read post
A Cell-Based ADCC Bioassay Comparison
Read post
Svar Complement Assays: Analyzing How Drug Candidates Affect the Complement System
Read post
Factors Affecting the Immunogenicity of Biopharmaceuticals
Read post
Functional Assays for Biopharmaceutical Development Success
Read post
Navigating the Complexities of Cell-based Assays in GMP QC Testing: The Journey to Robust Assays
Read post
Behind the Scenes at Novartis: The Development of Robust Cell-Based Assays for Gene Therapy
Read postContact our CRO Services team
Write us a message and a service specialist will get in touch